findmyKOL
Clinical trialNCT03491462CompletedPhase 3Interventional

Arimoclomol in Amyotropic Lateral Sclerosis

SponsorZevraDenmarkEnrollment245Amyotrophic Lateral Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Catholic University Leuven

    Leuven, Belgium

Canada
  • London Health Sciences Centre

    London, Ontario, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

  • Montreal Neurological Institute and Hospital

    Montreal, Quebec, Canada

France
  • Centre Hospitalier Regional Universitaire (chru) Montpellier - Hopital Gui de Chauliac

    Montpellier, France

  • Groupe Hospitalier Pitie-Salpetriere - Centre D'Investigation Clinique Neurosciences 1422

    Paris, France

Germany
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (cvk) - Ambulanz Fuer Als Und Andere Motoneuronenerkrankungen

    Berlin, Germany

  • Medizinische Hochschule Hannover (mhh) - Klinik Fuer Neurologie

    Hanover, Germany

  • Universitaetsklinikum Ulm - Klinik Fuer Neurologie

    Ulm, Germany

Italy
  • Instituti Clinica Scientifici Maugeri - Irccs

    Milan, Italy

  • Azienda Ospedaliero Universitaria (auo) Di Torino - Citta'Della Salute E Della Scienza Di Torino

    Torino, Italy

Netherlands
  • University Medical Center Utrecht

    Utrecht, Netherlands

Poland
  • Centrum Medyczne Neuroprotect

    Warsaw, Poland

  • Citi Clinic

    Warsaw, Poland

Spain
  • Hospital Universitario Vall D'Hebron Als Unit. Consultas Externas; Office: 9-10-11

    Barcelona, Spain

  • Hospital Carlos Iii - Hospital Universitario la Paz, Als Unit

    Madrid, Spain

Sweden
  • Umeå University Hospital

    Umeå, Sweden

Switzerland
  • Kantonsspital St.Gallen, Muskelzentrum/als Clinic

    Sankt Gallen, Switzerland

United Kingdom
  • Leonard Wolfson Experimental Neurology Centre

    London, United Kingdom

United States
  • Honorhealth Neurology

    Phoenix, Arizona, United States

  • St. Joseph'S Hospital and Medical Center (sjhmc) - Barrow Neurological Institute (bni) - the Gregory W. Fulton Als and Neuromuscular Disease Center

    Phoenix, Arizona, United States

  • Uc Irvine Health Als and Neuromuscular Center

    Orange, California, United States

  • University of Miami

    Miami, Florida, United States

  • University of Kansas Medical Center (kumc) - Landon Center on Aging

    Kansas City, Kansas, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • Providence Brain & Spine Institute

    Portland, Oregon, United States

  • University of Pensylvania, Perelman Center for Advanced Medicine - Penn Neuroscience Center

    Philadelphia, Pennsylvania, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • University of Virginia Health System

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2018
Primary completion
18 Dec 2020
Completion
18 Dec 2020
Last update posted
24 Aug 2023
Registered enrollment
245
Registry id
NCT03491462

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.